Paclitaxel analogs modified in ring C: Synthesis and biological evaluation

Tetrahedron

Volumn 53, Issue 10, 1997, Pages 3441-3456

  Liang, Xian ^a   Kingston, David G I ^a   Long, Byron H ^b   Fairchild, Craig A ^b   Johnston, Kathy A ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PACLITAXEL DERIVATIVE; TAXANE DERIVATIVE;

ARTICLE; CELL LINE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MICROTUBULE ASSEMBLY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS; TUMOR CELL CULTURE;

EID: 0031562458     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(97)00074-4     Document Type: Article

References (22)

1. 1. (a) Holmes, F. A.; Kudelka, A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1994; Vol. ACS Symposium Series 583; pp 31-57.
2. (b) Arbuck, S. G.; Blaylock, B. A. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press, Inc.: Boca Raton, FL, 1995; pp 379-415.
3. (c) McGuire, W. P.; Rowinsky, E. K., Eds. Paclitaxel in Cancer Treatment; Marcel Dekker, Inc.: New York, Basel, Hong Kong, 1995; Vol. 8; pp 1-349.
4. 2. (a) Chen, S.-H.; Farina, V. Paclitaxel Structure-Activity Relationships and Core Skeletal Rearrangements. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I. and Vyas, D. M., Eds.; ACS Symposium Series 583, American Chemical Society: Washington, DC, 1994; pp 247-261.
5. (b) Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Glowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. The Medicinal Chemistry of Taxol. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press, Inc.: Boca Raton, FL, 1995; pp 317-375.
6. (c) Kingston, D. G. I. Pharmac. Ther. 1991, 52, 1-34.
7. (d) Kingston, D. G. I. Trends Biotechnol. 1994, 12, 222-227.
8. (e) Kingston, D. G. I. Recent Advances in the Chemistry and Structure-Activity Relationships of Paclitaxel. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I. and Vyas, D. M., Ed.; American Chemical Society: Washington, DC, 1994; Vol. ACS Symposium Series 583; pp 203-216.
9. (f) Kingston, D. G. I. History and Chemistry. In Paclitaxel in Cancer Treatment; McGuire, W. P. and Rowinsky, E. K., Ed.; Marcel Dekker, Inc.: New York, Basel, Hong Kong, 1995; Vol. 8; pp 1-33.
10. (g) Nicolaou, K. C.; Dai, W.-M.; Guy, R. K. Angew. Chem. Int. Ed. Engl. 1994, 33, 15-44.
11. 3. (a) Samaranayake, G.; Magri, N. F.; Jitrangsri, C.; Kingston, D. G. I. J. Org. Chem. 1991, 56, 5114-5119.
12. (b) Chen, S.; Huang, S.; Wei, J.; Farina, V. Tetrahedron 1993, 49, 2805-2828.
13. 4. Klein, L. L.; Maring, C. J.; Li, L.; Yeung, C. M.; Thomas, S. A.; Grampovnik, D. J.; Plattner, J. J.; Henry, R. F. J. Org. Chem. 1994, 59, 2370-2373.
14. 5. Bouchard, H.; Pulicani, J.-P.; Vuilhorgne, M.; Bourzat, J.-D.; Commerçon, A. Tetrahedron Lett. 1994, 35, 9713-9716.
15. 6. Liang, X.; Kingston, D. G. I. Tetrahedron Lett. 1995, 36, 7795-7798.
16. 7. Chen, S.-H.; Huang, S.; Roth, G. P. Tetrahedron Lett., 1995, 36, 8933-8936.
17. 8. (a) Liang, X.; Kingston, D. G. I.; Lin, C. M.; Hamel, E. Tetrahedron Lett., 1995, 36, 2901-1904.
18. (b) Johnson, R. A.; Nidy, E. G.; Dobrowolski, P. J.; Gebhard, I.; Quails, S. J.; Wicnienski, N. A.; Kelly, R. C. Tetrahedron Lett. 1994, 35, 7893-7896.
19. 9. Miller, R. W.; Powell, R. G.; Smith, C. R., Jr.; Arnold, E.; Clardy, J. J. Org. Chem. 1981, 46, 1469-1474.
20. 10. Bender, M. L.; Reinstein, J. A.; Silver, M. S.; Mikulak, R. J. Amer. Chem. Soc., 1965, 87, 4545-4553.
21. 11. Griffith, W. P.; Ley, S. V. Aldrichimica Acta, 1990, 23, 13.
22. 12. Assay carried out by Drs. E. Hamel and C. M. Lin.